According to the report, the global plasma fractionation market is expected to generate around $36.8 bn by 2025, at a CAGR of around 7.2% between 2019 and 2025. Worldwide Trends in Plasma ...
The starting material for virtually all pharmaceuticals and biologics is a synthetic or chemical. Human plasma-derived therapies are one of the few exceptions. A number of fragile proteins can be ...
BMC’s written reply to the Assembly in the plasma fiasco has raised more questions that answers. While the civic body has submitted that no plasma was sent out of Maharashtra from 2023 to May 2026, ...
CHARLESTON, S.C.--(BUSINESS WIRE)--Plasma Technologies LLC (PlasmaTech), a plasma biologics technology company, announced that its novel human plasma fractionation process has been shown to achieve a ...
IRVING, Texas--(BUSINESS WIRE)--Fluor Corporation (NYSE: FLR) announced today that Grifols’ North Fractionation Facility in Clayton, N.C., was named the International Society for Pharmaceutical ...
The NHS has resumed using UK-sourced blood plasma products for the first time since a 1988 ban. The move is part of efforts to reduce reliance on imported plasma-derived medicines. The Department of ...
The New Times on MSN
RBC explores new use for excess plasma from blood donations
Rwanda is looking at how to make use of surplus plasma from blood donations, with much of it currently not being used in hospitals. In other countries, excess plasma, the liquid part of blood, is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results